FAQ – Aegerion Pharmaceuticals

What does Aegerion Pharmaceuticals specialize in?

Aegerion Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapies for patients with rare and often life-threatening lipid disorders.

What products does Aegerion currently offer?

Aegerion’s flagship product is Juxtapid® (lomitapide), a treatment for patients with homozygous familial hypercholesterolemia (HoFH)—a rare genetic condition that causes extremely high cholesterol levels.

Who is eligible to use Juxtapid® (lomitapide)?

Juxtapid is approved for patients with a confirmed diagnosis of HoFH. It should be prescribed and monitored by a healthcare provider experienced in lipid disorders and managing HoFH.

How does Juxtapid work?

Juxtapid works by inhibiting the microsomal triglyceride transfer protein (MTP), which reduces the production of LDL cholesterol in the liver and intestines.

Are there side effects associated with Juxtapid?

Yes, common side effects include gastrointestinal issues (such as diarrhea, nausea, and abdominal pain), as well as potential liver-related effects. Regular monitoring of liver enzymes is required.

How can patients access Aegerion’s therapies?

Aegerion offers patient support programs and works with healthcare providers, insurance companies, and specialty pharmacies to ensure eligible patients can access their medications.

Does Aegerion offer financial assistance for treatment?

Yes, Aegerion may provide financial assistance or co-pay support to eligible patients through its patient support programs. Contact the support team or visit the company’s website for details.

Meet our Pharmacist

On the other hand we denounce with righteous indignation and dislike men who are so beguiled and demoralized by the charms of pleasure of the moment so blinded by desire that they cannot foresee the pain and trouble that are bound.

Pharmacist